D Y Mason

TL;DR: The HM57 mAb is well suited for the detection of the mb-1 molecule as a pan-B-cell marker for the diagnosis of immature and mature B-cell malignancies, because of the variable and generally weak signals on cytocentrifuge preparations.

TL;DR: Skin biopsies from nine patients with a histological and/or clinical diagnosis of cutaneous lymphocytoma, lymphoplasia or Jessner's lymphocytic infiltrate were examined by immunoenzymatic labelling with a panel of monoclonal antibodies against lymphocytes and accessory cells.

TL;DR: Investigation of cutaneous non-Hodgkin lymphomas showed similarities with nodal lymphomas in terms of expression of lymphoid subset markers and composition of the non-neoplastic white cell infiltrate, and immunophenotypic investigations form a useful supplement to their histogenetic characterisation and may provide a common conceptual basis for their classification.

TL;DR: It is suggested that immunocytochemical labelling should be used in cases of suspected carcinoma whenever conventional examination of marrow smears yields negative results, and furthermore that the technique is of value for identifying the true nature of poorly differentiated neoplasms in bone marrow.

TL;DR: These antibodies have proven to be excellent reagents for the immunocytochemical detection of S-100 in normal and pathologic human tissue and despite the fact that the immunoblotting reactions of the antibodies obtained from both fusions were indistinguishable, different immunohistologic labeling patterns could be observed.